Grifols’ Innovation Strategy in the Plasma Medicine Space
XTalks
DECEMBER 12, 2023
Our pipeline, for example, includes a new class of recombinant antibodies. Right now, they are doing what is probably the most advanced work in the field of polyclonal recombinant antibody therapies. The science is brilliant.
Let's personalize your content